Immunopathogenesis of respiratory syncytial virus bronchiolitis.

BACKGROUND The objective of this study was to elucidate the relation between respiratory syncytial virus (RSV) infection and cytokine/chemokine concentrations, as well as the impact that these factors have on the severity of bronchiolitis. METHODS Children <24 months old who presented to the emergency department with clinical symptoms of bronchiolitis were prospectively enrolled in the study. Nasal-wash samples were analyzed to identify viral pathogens and to quantify RSV and cytokine/chemokine concentrations. Severe cases of disease were defined as those requiring hospitalization, and severity was further determined on the basis of the duration of supplemental-oxygen and/or intravenous-fluid therapy. RESULTS A total of 101 children were enrolled, 63 of whom were infected with RSV and 13 of whom were infected with other respiratory viruses; in 22 children, no virus was detected. RSV bronchiolitis was associated with a greater inflammatory response than was non-RSV bronchiolitis, although RSV infection was not associated with more-severe disease. Levels of interleukin (IL)-6, IL-8, IL-10, interferon (IFN)-gamma, and macrophage inflammatory protein (MIP)-1beta were significantly inversely correlated with the duration of supplemental-oxygen therapy. CONCLUSION The robust inflammatory response associated with RSV infection does not contribute to the severity of RSV bronchiolitis any more than it contributes to the severity of non-RSV bronchiolitis. Elevated levels of proinflammatory mediators IL-6, IL-8, IFN-gamma, and MIP-1beta, as well as of the regulatory cytokine IL-10, may be protective against hypoxia in bronchiolitis.

[1]  R. Garofalo,et al.  Differential response of dendritic cells to human metapneumovirus and respiratory syncytial virus. , 2006, American journal of respiratory cell and molecular biology.

[2]  R. Garofalo,et al.  Human Metapneumovirus Induces a Profile of Lung Cytokines Distinct from That of Respiratory Syncytial Virus , 2005, Journal of Virology.

[3]  C. Hart,et al.  Production of chemokines in the lungs of infants with severe respiratory syncytial virus bronchiolitis. , 2005, The Journal of infectious diseases.

[4]  R. Holman,et al.  Lower Respiratory Tract Infections Among American Indian and Alaska Native Children and the General Population of U.S. Children , 2005, The Pediatric infectious disease journal.

[5]  R. Garofalo,et al.  A comparison of epidemiologic and immunologic features of bronchiolitis caused by influenza virus and respiratory syncytial virus , 2005, Journal of medical virology.

[6]  Gyeong Hoon Lee,et al.  Relationship between atopic status and nasal interleukin 10 and 11 levels in infants with respiratory syncytial virus bronchiolitis. , 2005, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[7]  J. D. Beckham,et al.  Respiratory viral infections in patients with chronic, obstructive pulmonary disease , 2004, Journal of Infection.

[8]  A. Randolph,et al.  Efficacy of interventions for bronchiolitis in critically ill infants: A systematic review and meta-analysis* , 2004, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[9]  B. Graham,et al.  Prolonged Production of TNF-α Exacerbates Illness during Respiratory Syncytial Virus Infection1 , 2004, The Journal of Immunology.

[10]  P. Piedra,et al.  Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by NMSO3 in tissue culture assays. , 2004, Antiviral research.

[11]  O. Ruuskanen,et al.  Respiratory Picornaviruses and Respiratory Syncytial Virus as Causative Agents of Acute Expiratory Wheezing in Children , 2004, Emerging infectious diseases.

[12]  S. J. Hoffman,et al.  Differential production of inflammatory cytokines in primary infection with human metapneumovirus and with other common respiratory viruses of infancy. , 2004, The Journal of infectious diseases.

[13]  N. Lukacs,et al.  Respiratory syncytial virus-induced chemokine production: linking viral replication to chemokine production in vitro and in vivo. , 2004, The Journal of infectious diseases.

[14]  A. Osterhaus,et al.  Real-Time Reverse Transcriptase PCR Assay for Detection of Human Metapneumoviruses from All Known Genetic Lineages , 2004, Journal of Clinical Microbiology.

[15]  S. Leader,et al.  Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000. , 2003, The Journal of pediatrics.

[16]  S. Johnston,et al.  Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis. , 2003, American journal of respiratory and critical care medicine.

[17]  G. Boivin,et al.  Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by ribavirin and immune serum globulin in vitro. , 2003, Antiviral research.

[18]  U. Schauer,et al.  Respiratory syncytial virus induces prostaglandin E2, IL‐10 and IL‐11 generation in antigen presenting cells , 2002, Clinical and experimental immunology.

[19]  L. Anderson,et al.  Peripheral blood mononuclear cells from infants hospitalized because of respiratory syncytial virus infection express T helper-1 and T helper-2 cytokines and CC chemokine messenger RNA. , 2002, The Journal of infectious diseases.

[20]  P. Piedra.  Future directions in vaccine prevention of respiratory syncytial virus. , 2002, The Pediatric infectious disease journal.

[21]  W. Gruber,et al.  Illness severity, viral shedding, and antibody responses in infants hospitalized with bronchiolitis caused by respiratory syncytial virus. , 2002, The Journal of infectious diseases.

[22]  B. Graham,et al.  The Role of IFN in Respiratory Syncytial Virus Pathogenesis , 2002, The Journal of Immunology.

[23]  Wendy J. Pomerantz,et al.  New approaches to respiratory infections in children. Bronchiolitis and croup. , 2002, Emergency medicine clinics of North America.

[24]  K. Tsubota,et al.  Suppressive effect of locally produced interleukin‐10 on respiratory syncytial virus infection , 2001, Immunology.

[25]  R. Garofalo,et al.  Macrophage Inflammatory Protein-1α (Not T Helper Type 2 Cytokines) Is Associated with Severe Forms of Respiratory Syncytial Virus Bronchiolitis , 2001 .

[26]  L. Bont,et al.  Local interferon-gamma levels during respiratory syncytial virus lower respiratory tract infection are associated with disease severity. , 2001, The Journal of infectious diseases.

[27]  J. Cruse,et al.  10 - Cytokines and Chemokines , 2004 .

[28]  W. P. Glezen,et al.  HLA-restricted CD8+ cytotoxic T lymphocyte, interferon-gamma, and interleukin-4 responses to respiratory syncytial virus infection in infants and children. , 2001, The Journal of infectious diseases.

[29]  P. Openshaw,et al.  IL-12-Activated NK Cells Reduce Lung Eosinophilia to the Attachment Protein of Respiratory Syncytial Virus But Do Not Enhance the Severity of Illness in CD8 T Cell-Immunodeficient Conditions1 , 2000, The Journal of Immunology.

[30]  K. Bendelja,et al.  Predominant type‐2 response in infants with respiratory syncytial virus (RSV) infection demonstrated by cytokine flow cytometry , 2000, Clinical and experimental immunology.

[31]  R. Holman,et al.  Bronchiolitis-associated hospitalizations among US children, 1980-1996. , 1999, JAMA.

[32]  L. Bont,et al.  Peripheral blood cytokine responses and disease severity in respiratory syncytial virus bronchiolitis. , 1999, The European respiratory journal.

[33]  H. Rosenberg,et al.  Respiratory syncytical virus-induced chemokine expression in the lower airways: eosinophil recruitment and degranulation. , 1999, American journal of respiratory and critical care medicine.

[34]  O. Ramilo,et al.  Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease. , 1999, The Pediatric infectious disease journal.

[35]  P. Piedra,et al.  Dual Respiratory Virus Infections , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[36]  C. Hart,et al.  Immunological responses to respiratory syncytial virus infection in infancy , 1997, Archives of disease in childhood.

[37]  J. Englund,et al.  Rapid diagnosis of respiratory syncytial virus infections in immunocompromised adults , 1996, Journal of clinical microbiology.

[38]  R. Silverman,et al.  Respiratory syncytial virus induces interleukin-10 by human alveolar macrophages. Suppression of early cytokine production and implications for incomplete immunity. , 1995, The Journal of clinical investigation.

[39]  I. Wortman,et al.  Nasal cytokine production in viral acute upper respiratory infection of childhood. , 1995, The Journal of infectious diseases.

[40]  B. García-Barreno,et al.  Evaluation of immunoglobulin E-specific antibodies and viral antigens in nasopharyngeal secretions of children with respiratory syncytial virus infections , 1993, Journal of clinical microbiology.

[41]  L. Taussig,et al.  THE TUCSON CHILDREN'S RESPIRATORY STUDY. II. LOWER RESPIRATORY TRACT ILLNESS IN THE FIRST YEAR OF LIFE , 1989, American journal of epidemiology.

[42]  W. Morgan,et al.  The Tucson Children's Respiratory Study. I. Design and implementation of a prospective study of acute and chronic respiratory illness in children. , 1989, American journal of epidemiology.

[43]  R. Douglas,et al.  Respiratory syncytial virus infections in infants: quantitation and duration of shedding. , 1976, The Journal of pediatrics.

[44]  T. Kimman,et al.  Association of severe respiratory syncytial virus bronchiolitis with interleukin-4 and interleukin-4 receptor alpha polymorphisms. , 2003, The Journal of infectious diseases.

[45]  Larry Borish,et al.  Cytokines and chemokines , 2003 .

[46]  L. Bont,et al.  CONCISE COMMUNICATION Local Interferon- g Levels during Respiratory Syncytial Virus Lower Respiratory Tract Infection Are Associated with Disease Severity , 2001 .